Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study-Reference-Cited by-同舟云学术

Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study

Published:2018-05 Issue:5 Volume:41 Page:576-585
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Perreault Sylvie¹^ORCID,Shahabi Payman²³⁴,Côté Robert⁵⁶,Dumas Stéphanie¹²³,Rouleau-Mailloux Étienne²³⁴,Feroz Zada Yassamin²³,Provost Sylvie²³,Mongrain Ian²³,Dorais Marc⁷,Huynh Thao⁸,Kouz Simon⁹,Diaz Ariel⁴¹⁰,Blostein Mark¹¹,de Denus Simon¹²³,Turgeon Jacques¹¹²,Ginsberg Jeffrey¹³,Lelorier Jacques⁴¹²,Lalonde Lyne¹,Busque Lambert⁴¹⁴,Kassis Jeannine⁴¹⁴,Talajic Mario³,Tardif Jean-Claude³⁴,Dubé Marie-Pierre²³⁴^ORCID

Affiliation:

1. Faculty of Pharmacy; Université de Montréal; Montreal, Quebec Canada

2. Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre; Montreal Quebec Canada

3. Montreal Heart Institute; Montreal Quebec Canada

4. Faculty of Medicine; Université de Montréal; Montreal Quebec Canada

5. Department of Neurology and Neurosurgery; McGill University; Montreal Quebec Canada

6. Department of Neurology and Neurosurgery; Montreal General Hospital; Montreal Quebec Canada

7. StatSciences Inc.; Notre-Dame-de-l'Île-Perrot, Quebec Canada

8. Department of Medicine; Montreal General Hospital; Montreal Quebec Canada

9. Département de médecine spécialisée; Centre hospitalier régional de Lanaudière; Joliette Quebec Canada

10. CIUSSS-MCQ, Université de Montréal; Campus Mauricie, Trois-Rivières, Quebec Canada

11. Division of Hematology, Department of Medicine; Sir Mortimer B. Davis Jewish General Hospital; Montreal Quebec Canada

12. Centre Hospitalier de l'Université de Montréal; Montreal Quebec Canada

13. Department of Medicine; McMaster University; Hamilton Ontario Canada

14. Department of Medicine; Maisonneuve-Rosemont Hospital; Montreal Quebec Canada

Funder

Canadian Institutes of Health Research

Center of Excellence in Personalized Medicine

Canadian Gene Cure Foundation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference39 articles.

1. Warfarin pharmacogenetics;Johnson;Trends Cardiovasc Med.,2015

2. Warfarin: what are the clinical implications of an out-of-range-therapeutic international normalized ratio?;Merli;J Thromb Thrombolysis.,2009

3. What is the role of pharmacogenetics in optimization of warfarin dosing?;Carnes;Trends Cardiovasc Med.,2015

4. Genetic and clinical factors relating to warfarin dosing;Jonas;Trends Pharmacol Sci.,2009

5. Oral anticoagulant therapy. Antithrombotic Therapy and Prevention of Thrombosis. 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Ageno;Chest.,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study;Thrombosis Research;2024-05

2. Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older Adults;Pharmaceuticals;2024-01-30

3. Effectiveness and safety of apixaban and rivaroxaban vs warfarin in patients with atrial fibrillation and chronic kidney disease;World Journal of Nephrology;2023-12-25

4. Integrated analysis of clinical and genetic factors on the interindividual variation of warfarin anticoagulation efficacy in clinical practice;BMC Cardiovascular Disorders;2023-05-31

5. Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary Intervention;CJC Open;2023-01